secwatch.observer — SEC 8-K summary
======================================

Issuer:     Longboard Pharmaceuticals, Inc. (—)
CIK:        0001832168
Form:       8-K
Filed at:   2024-12-02T23:59:59+00:00
Accession:  0001140361-24-048133
Event type: m_and_a
Sentiment:  neutral
Materiality: 1.00
Item codes: 1.02, 2.01, 5.03, 3.01, 3.03, 5.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Longboard acquired by H. Lundbeck for $60.00 per share; Merger completed Dec 2, 2024
--------------------------------------------------------------------------------

- Acquisition closed on Dec 2, 2024; Longboard becomes indirect wholly owned subsidiary of H. Lundbeck A/S.
- Offer expired Nov 27, 2024; 30,618,257 shares (88.6%) validly tendered; all conditions satisfied.
- Each share converted into $60.00 cash; outstanding options and RSUs cashed out at same price.
- All pre-merger directors and officers resigned; Thomas Gibbs (President), Thomas Forrester (Secretary), Markus Kede (Treasurer) appointed.
- Shares will be delisted from Nasdaq and registration terminated under Exchange Act.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1832168/000114036124048133/0001140361-24-048133-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1832168/000114036124048133/ef20039392_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-048133

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer